| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/07/2002 | US20020028195 Viruses for the treatment of cellular proliferative disorders |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421063A1 Methods for stable transduction of cells with viral vectors |
| 03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 03/06/2002 | EP1183383A1 Siv-based packaging-deficient vectors |
| 03/06/2002 | EP1183381A2 Synthetic gene for expressing active retroviral protein in eukaryotes |
| 03/06/2002 | EP1183380A1 Compositions and methods useful for production of recombinant viruses which require helper viruses |
| 03/06/2002 | EP1183371A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 03/06/2002 | EP1183332A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 03/06/2002 | EP1183051A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1003534B1 Reovirus for the treatment of neoplasia |
| 03/06/2002 | EP0848757B1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/06/2002 | EP0736100B1 Recombinant protein production in bovine adenovirus expression vector system |
| 03/06/2002 | EP0694071B1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells |
| 03/06/2002 | CN1338513A Recombinant adenovirus for preventing baby's diarrhea |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080300C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 03/05/2002 | US6352856 A poxvirus geneome containing a replication defective retroviral proviral genome; for gene therapy or tumor therapy, therapy for cystic fibrosis, hemophilia |
| 03/05/2002 | US6352825 Oligonucleotide primers which have been elongated at the 3' ends with highly conserved sequences; accurate diagnosis of human papilloma virus and cervical cancer detection |
| 03/05/2002 | US6352695 Methods and compositions for the selective modification of nucleic acids |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002015904A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/28/2002 | WO2001083747A3 Prion proteins and their uses |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025515 Inviable virus particles as scaffolds for constructing flexible detection systems |
| 02/28/2002 | CA2418006A1 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | CA2415793A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182254A1 Methods for separating, fractionating and analyzing gene of virus existing in water |
| 02/27/2002 | EP1181382A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 02/27/2002 | EP1181353A1 Inducible packaging cell lines for lentivirus vectors |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181050A1 Methods for preventing reactivation of latent virus and controlling virus replication |
| 02/27/2002 | EP1180938A2 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 02/27/2002 | EP1180937A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/27/2002 | CN1337463A Breeding of hepatitis A virus Chinese strain and attenuated strain and its complementary DNA sequence |
| 02/27/2002 | CN1079833C Recombinant P53 adenovirus method and compositions |
| 02/26/2002 | US6350575 Helper viruses for the preparation of recombinant viral vectors |
| 02/21/2002 | WO2002014526A2 Replication competent aav helper functions |
| 02/21/2002 | WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | WO2002014471A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | WO2002014362A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/21/2002 | WO2002013855A2 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | WO2001064860A3 Recombinant influenza a viruses |
| 02/21/2002 | WO2001062827A3 N-maleimidyl polymer derivatives |
| 02/21/2002 | WO2000069269A9 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419338A1 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/20/2002 | EP1180167A1 In vivo selection method for determining inhibitory rna molecules |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 02/20/2002 | EP1180158A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |
| 02/20/2002 | EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes |
| 02/20/2002 | EP1180153A1 Phage-dependent super-production of biologically active proteins and peptides |
| 02/19/2002 | US6348336 Process for purification of PCR test samples |
| 02/14/2002 | WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | WO2002012477A2 Enhanced replication of hcv rna |
| 02/14/2002 | WO2002012455A1 LARGE-SCALE RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PRODUCTION AND PURIFICATION |
| 02/14/2002 | WO2002012454A1 Virus-like micrograins and process for producing the same |
| 02/14/2002 | WO2002012435A1 Method of producing infectious reovirus |
| 02/14/2002 | WO2002011540A1 Rotavirus vaccine formulations |
| 02/14/2002 | WO2001059093A3 Full-length infectious cdna clones of tick borne flavivirus |
| 02/14/2002 | WO2001038362A3 Production of vaccines |
| 02/14/2002 | US20020019050 Hybrid microorganism for use in gene therapy |
| 02/14/2002 | US20020019041 Storing adenoviruses; preparing liquid composition, maintain liquid at freezing, monitor adenovirues for activity |
| 02/14/2002 | US20020019037 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 02/14/2002 | US20020018784 Vaccine against mumps containing a jeryl-lynn virus strain |
| 02/14/2002 | US20020018765 Genetic engineering; transforming genes; Dna viruses |
| 02/14/2002 | CA2418091A1 Virus-like particles and process for producing the same |
| 02/14/2002 | CA2416633A1 Enhanced replication of hcv rna |
| 02/14/2002 | CA2415333A1 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/13/2002 | EP1179082A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179054A2 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 02/13/2002 | EP0830142B1 Prrs (porcine reproductive and respiratory syndrome) virus vaccine |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/12/2002 | US6346415 Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors |
| 02/12/2002 | US6346408 Method of allophycocyanin inhibition of enterovirus and influenza virus reproduction resulting in cytopathic effect |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | CA2065847C Rotavirus reassortant vaccine |
| 02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
| 02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010353A1 Lipo-viro-particle complexes, preparation method and uses |
| 02/07/2002 | WO2002009750A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | WO2001050866A3 Method and device for sanitation using bacteriophages |
| 02/07/2002 | WO2001039801A3 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 02/07/2002 | US20020015945 Method for the purification of alphavirus replicon particles |
| 02/07/2002 | US20020015937 Deactivation of microorganisms; mix modulators and sample, expose sample to pressure, release pressure, recover sample |
| 02/07/2002 | US20020015710 Mimicing the conformational neutralizing epitopes on papilloma virions |
| 02/07/2002 | US20020014111 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 02/07/2002 | CA2417719A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |